The Beauty Health Company (NASDAQ:SKIN) Receives $1.38 Consensus Target Price from Analysts

The Beauty Health Company (NASDAQ:SKIN) has earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $1.3750.

A number of brokerages recently weighed in on SKIN. Weiss Ratings downgraded shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 23rd. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Roth Capital reaffirmed a “buy” rating and issued a $2.00 target price (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Finally, TD Cowen reduced their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating for the company in a research note on Wednesday, August 12th.

Beauty Health Price Performance

Beauty Health stock opened at $0.69 on Tuesday. The stock has a market capitalization of $89.80 million, a PE ratio of -3.14 and a beta of 1.00. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. Beauty Health has a twelve month low of $0.55 and a twelve month high of $2.69. The company has a 50 day moving average of $0.73 and a 200-day moving average of $0.81.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.02) EPS for the quarter, hitting the consensus estimate of ($0.02). The firm had revenue of $72.11 million for the quarter, compared to analysts’ expectations of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. On average, equities research analysts anticipate that Beauty Health will post -0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Several hedge funds have recently added to or reduced their stakes in SKIN. Capricorn Fund Managers Ltd acquired a new position in shares of Beauty Health in the first quarter valued at $17,270,000. Woodline Partners LP lifted its position in Beauty Health by 255.9% during the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after acquiring an additional 4,263,997 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after acquiring an additional 3,225,668 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares during the period. Finally, State Street Corp grew its position in shares of Beauty Health by 0.9% in the fourth quarter. State Street Corp now owns 1,871,527 shares of the company’s stock valued at $2,601,000 after purchasing an additional 16,493 shares during the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.